AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $24,343,000 | -2.2% | 823,791 | +57.2% | 1.42% | -8.2% |
| Q1 2019 | $24,895,000 | +98.4% | 524,091 | +50.7% | 1.55% | +61.1% |
| Q4 2018 | $12,551,000 | +12.7% | 347,691 | +92.1% | 0.96% | +56.6% |
| Q3 2018 | $11,140,000 | +52.7% | 180,991 | +67.6% | 0.62% | +48.6% |
| Q2 2018 | $7,296,000 | -17.6% | 108,000 | -33.9% | 0.41% | -9.2% |
| Q1 2018 | $8,859,000 | +420.8% | 163,300 | +366.6% | 0.46% | +508.0% |
| Q3 2017 | $1,701,000 | -18.5% | 35,000 | -23.9% | 0.08% | -29.2% |
| Q1 2017 | $2,086,000 | – | 46,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |